Icon Advisers’s Medicines Co MDCO Stock Holding History

Icon Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-87,000	Closed	-$2.92M	–	350
2013 Q3	$2.92M	Buy	+87,000	New	+$2.77M	0.22%	107

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAC

Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Icon Advisers's MDCO Position: Q4 2013 in Review

Icon Advisers sold out of Medicines Co (MDCO) in Q4 2013, closing a stake of 87,000 shares — an estimated $2.92M sold.

Icon Advisers first reported a position in MDCO in Q3 2013 and held it in 1 quarter. The position peaked at $2.92M in Q3 2013. 182 funds tracked by Wall St. Rank hold MDCO as of Q4 2013.

Icon Advisers reported no remaining Medicines Co position as of Q4 2013 after selling out during the quarter.
Icon Advisers sold 87,000 Medicines Co shares in Q4 2013, an estimated $2.92M.
Icon Advisers first reported a position in Medicines Co in Q3 2013 and held it in 1 quarter.
Icon Advisers's Medicines Co position peaked at $2.92M in Q3 2013.
182 funds tracked by Wall St. Rank held Medicines Co as of Q4 2013.

Based on Icon Advisers's 13F filing for Q4 2013, filed 10 Feb 2014.